Abstract

Recently, there has been great interest in the biological effects of equol, a metabolite of daidzein produced by intestinal flora. In this study, we used a newly isolated intestinal bacterium from healthy human faeces to investigate the effects of intestinal bacteria on the in vitro metabolism of daidzein by faecal flora in mice and a human male equol producer. The 16S rDNA partial sequence (1394 bp) of strain TM-20 that was isolated from infant faeces exhibited a 99% similarity to that of Bifidobacterium pseudocatenulatum . Therefore, this strain was identified as belonging to the genus Bifidobacterium . In faecal suspensions from mice, equol concentrations were significantly lower in the control faecal suspension than in the faecal suspension supplemented with the high concentration of strain TM-20. However, equol concentrations were significantly higher in the control faecal suspension than in the faecal suspension supplemented with the low concentration of strain TM- 20. In faecal suspensions from a human male equol producer, equol concentrations were lower in the control faecal suspension than in the faecal suspension supplemented with the high concentration of strain TM-20. However, equol concentrations were higher in the control faecal suspension than in the fecal suspension supplemented with the low concentration of strain TM-20. Metabolic activity of the faecal equol production in mice and humans may be changed by some types of bifidobacteria. To our knowledge, this is the first report of a Bifidbacterium sp. that is capable of changing the faecal equol production from daidzein in vitro. Key words: daidzein, equol, faecal flora, bifidobacteria

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.